{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:44:10Z","timestamp":1780098250472,"version":"3.54.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Innovation Program of Hunan Province","award":["2021RC4056"],"award-info":[{"award-number":["2021RC4056"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40804"],"award-info":[{"award-number":["2022JJ40804"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11307-024-01970-6","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:06:47Z","timestamp":1736874407000},"page":"120-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Inflammatory Activity of Extraocular Muscles in Thyroid Associated Orbitopathy by [68Ga]DOTATATE PET\/CT"],"prefix":"10.1007","volume":"27","author":[{"given":"Zhengquan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1745-3280","authenticated-orcid":false,"given":"Tingting","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-818X","authenticated-orcid":false,"given":"Jia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-8943","authenticated-orcid":false,"given":"Shuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"1970_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K et al (2016) The 2016 European thyroid association\/European group on graves\u2019 orbitopathy guidelines for the management of graves\u2019 orbitopathy. Eur Thyroid J 5:9\u201326","journal-title":"Eur Thyroid J"},{"key":"1970_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/joim.13524","volume":"292","author":"L Bartalena","year":"2022","unstructured":"Bartalena L, Tanda ML (2022) Current concepts regarding Graves\u2019 orbitopathy. J Intern Med 292:692\u2013716","journal-title":"J Intern Med"},{"key":"1970_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","volume":"16","author":"PN Taylor","year":"2020","unstructured":"Taylor PN, Zhang L, Lee RWJ et al (2020) New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nat Rev Endocrinol 16:104\u2013116","journal-title":"Nat Rev Endocrinol"},{"key":"1970_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson A et al (2008) Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273\u2013285","journal-title":"Eur J Endocrinol"},{"key":"1970_CR5","first-page":"646","volume":"58","author":"Oculoplastic and Orbital Disease Group of Chinese Ophthalmological Society of Chinese Medical Association","year":"2022","unstructured":"Oculoplastic and Orbital Disease Group of Chinese Ophthalmological Society of Chinese Medical Association, Thyroid Group of Chinese Society of Endocrinology of Chinese Medical Association (2022) Chinese guideline on the diagnosis and treatment of thyroid-associated ophthalmopathy (2022). Chin J Ophthalmol 58:646\u2013668","journal-title":"Chin J Ophthalmol"},{"key":"1970_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12902-018-0240-8","volume":"18","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zhang S, Zhang Y et al (2018) A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy. BMC Endocr Disord 18:13","journal-title":"BMC Endocr Disord"},{"key":"1970_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.crad.2022.08.124","volume":"77","author":"J Civrny","year":"2022","unstructured":"Civrny J, Karhanova M, Hubnerova P, Schovanek J, Herman M (2022) MRI in the assessment of thyroid-associated orbitopathy activity. Clin Radiol 77:925\u2013934","journal-title":"Clin Radiol"},{"key":"1970_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s12020-021-02873-0","volume":"75","author":"R Ma","year":"2022","unstructured":"Ma R, Geng Y, Gan L et al (2022) Quantitative T1 mapping MRI for the assessment of extraocular muscle fibrosis in thyroid-associated ophthalmopathy. Endocrine 75:456\u2013464","journal-title":"Endocrine"},{"key":"1970_CR9","doi-asserted-by":"publisher","first-page":"20140677","DOI":"10.1259\/bjr.20140677","volume":"88","author":"R Kilicarslan","year":"2015","unstructured":"Kilicarslan R, Alkan A, Ilhan MM, Yetis H, Aralasmak A, Tasan E (2015) Graves\u2019 ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease. Br J Radiol 88:20140677","journal-title":"Br J Radiol"},{"key":"1970_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1259\/bjr\/56958444","volume":"82","author":"NI Dodds","year":"2009","unstructured":"Dodds NI, Atcha AW, Birchall D, Jackson A (2009) Use of high-resolution MRI of the optic nerve in Graves\u2019 ophthalmopathy. Br J Radiol 82:541\u2013544","journal-title":"Br J Radiol"},{"key":"1970_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/eje.0.1450107","volume":"145","author":"GJ Kahaly","year":"2001","unstructured":"Kahaly GJ (2001) Imaging in thyroid-associated orbitopathy. Eur J Endocrinol 145:107\u2013118","journal-title":"Eur J Endocrinol"},{"key":"1970_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/thy.2008.0298","volume":"19","author":"B Ujhelyi","year":"2009","unstructured":"Ujhelyi B, Erdei A, Galuska L et al (2009) Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in graves\u2019 ophthalmopathy. Thyroid 19:375\u2013380","journal-title":"Thyroid"},{"key":"1970_CR13","doi-asserted-by":"publisher","first-page":"791131","DOI":"10.3389\/fmed.2021.791131","volume":"8","author":"C Jiang","year":"2021","unstructured":"Jiang C, Deng Z, Huang J et al (2021) Monitoring and predicting treatment response of extraocular muscles in grave\u2019s orbitopathy by (99m)Tc-DTPA SPECT\/CT. Front Med (Lausanne) 8:791131","journal-title":"Front Med (Lausanne)"},{"key":"1970_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10792-019-01213-6","volume":"40","author":"D Liu","year":"2020","unstructured":"Liu D, Xu X, Wang S et al (2020) 99mTc-DTPA SPECT\/CT provided guide on triamcinolone therapy in Graves\u2019 ophthalmopathy patients. Int Ophthalmol 40:553\u2013561","journal-title":"Int Ophthalmol"},{"key":"1970_CR15","first-page":"830","volume":"57","author":"MT Tang","year":"2021","unstructured":"Tang MT, Zeng XY, Li Y et al (2021) [The application of (99)tc(m)-DTPA orbital SPECT\/CT in staging evaluation of thyroid associated ophthalmopathy]. Zhonghua Yan Ke Za Zhi 57:830\u2013836","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"1970_CR16","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.1210\/jc.2002-020790","volume":"87","author":"D Pasquali","year":"2002","unstructured":"Pasquali D, Notaro A, Bonavolonta G, Vassallo P, Bellastella A, Sinisi AA (2002) Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves\u2019 disease. J Clin Endocrinol Metab 87:5125\u20135129","journal-title":"J Clin Endocrinol Metab"},{"key":"1970_CR17","doi-asserted-by":"publisher","first-page":"E1630","DOI":"10.1152\/ajpendo.00177.2007","volume":"293","author":"I Cozma","year":"2007","unstructured":"Cozma I, Zhang L, Uddin J, Lane C, Rees A, Ludgate M (2007) Modulation of expression of somatostatin receptor subtypes in Graves\u2019 ophthalmopathy orbits: relevance to novel analogs. Am J Physiol Endocrinol Metab 293:E1630\u20131635","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1970_CR18","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/RLU.0b013e31821a2618","volume":"36","author":"R Pichler","year":"2011","unstructured":"Pichler R, Sonnberger M, Dorninger C, Assar H, Stojakovic T (2011) Ga-68-DOTA-NOC PET\/CT reveals active graves\u2019 orbitopathy in a single extraorbital muscle. Clin Nucl Med 36:900\u2013901","journal-title":"Clin Nucl Med"},{"key":"1970_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12020-007-0039-2","volume":"31","author":"H Sun","year":"2007","unstructured":"Sun H, Jiang XF, Wang S et al (2007) (99m)Tc-HYNIC-TOC scintigraphy in evaluation of active graves\u2019 ophthalmopathy (GO). Endocrine 31:305\u2013310","journal-title":"Endocrine"},{"key":"1970_CR20","first-page":"242","volume":"2","author":"R Zhao","year":"2012","unstructured":"Zhao R, Wang J, Deng J, Yang W (2012) Efficacy of (99m)Tc-EDDA\/HYNIC-TOC SPECT\/CT scintigraphy in graves\u2019 ophthalmopathy. Am J Nucl Med Mol Imaging 2:242\u2013247","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"1970_CR21","first-page":"1547","volume":"44","author":"G Burggasser","year":"2003","unstructured":"Burggasser G, Hurtl I, Hauff W et al (2003) Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with graves\u2019 disease. J Nucl Med 44:1547\u20131555","journal-title":"J Nucl Med"},{"key":"1970_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11864-022-00967-z","volume":"23","author":"E Fortunati","year":"2022","unstructured":"Fortunati E, Argalia G, Zanoni L, Fanti S, Ambrosini V (2022) New PET radiotracers for the imaging of neuroendocrine neoplasms. Curr Treat Options Oncol 23:703\u2013720","journal-title":"Curr Treat Options Oncol"},{"key":"1970_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejca.2021.01.008","volume":"146","author":"V Ambrosini","year":"2021","unstructured":"Ambrosini V, Kunikowska J, Baudin E et al (2021) Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer 146:56\u201373","journal-title":"Eur J Cancer"},{"key":"1970_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","volume":"19","author":"MH Shah","year":"2021","unstructured":"Shah MH, Goldner WS, Benson AB et al (2021) Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in Oncology. J Natl Compr Canc Netw 19:839\u2013868","journal-title":"J Natl Compr Canc Netw"},{"key":"1970_CR25","first-page":"129","volume":"7","author":"B Fallahi","year":"2019","unstructured":"Fallahi B, Manafi-Farid R, Eftekhari M et al (2019) Diagnostic fficiency of (68)Ga-DOTATATE PET\/CT as ompared to (99m)Tc-Octreotide SPECT\/CT andonventional orphologic odalities in euroendocrine umors. Asia Ocean J Nucl Med Biol 7:129\u2013140","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"1970_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0002-9394(14)72787-4","volume":"119","author":"GB Bartley","year":"1995","unstructured":"Bartley GB, Gorman CA (1995) Diagnostic criteria for Graves\u2019 ophthalmopathy. Am J Ophthalmol 119:792\u2013795","journal-title":"Am J Ophthalmol"},{"key":"1970_CR27","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L et al (2021) The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol 185:G43\u2013G67","journal-title":"Eur J Endocrinol"},{"key":"1970_CR28","first-page":"869","volume":"43","author":"CZ Jiang","year":"2018","unstructured":"Jiang CZ, Li XH, Deng HY et al (2018) Nontarget area and threshold selection in 99mTc-DTPA orbital SPECT\/CT imaging inthyroid associated ophthalmopathy. J Cent South Univ Med Sci 43:869\u2013874","journal-title":"J Cent South Univ Med Sci"},{"key":"1970_CR29","first-page":"3249","volume":"41","author":"M Crisp","year":"2000","unstructured":"Crisp M, Starkey KJ, Lane C, Ham J (2000) Adipogenesis in thyroid eye disease. Ophthalmol Vis Sci 41:3249\u20133255","journal-title":"Ophthalmol Vis Sci"},{"key":"1970_CR30","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1210\/jc.2004-0271","volume":"89","author":"D Seboek","year":"2004","unstructured":"Seboek D, Linscheid P, Zulewski H et al (2004) Somatostatin is expressed and secreted by human adipose tissue upon infection and inflammation. J Clin Endocrinol Metab 89:4833\u20134839","journal-title":"J Clin Endocrinol Metab"},{"key":"1970_CR31","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s00417-021-05339-1","volume":"259","author":"M Weber","year":"2021","unstructured":"Weber M, Deuschl C, Bechrakis N et al (2021) 18F-FDG-PET\/MRI in patients with Graves\u2019 orbitopathy. Graefes Arch Clin Exp Ophthalmol 259:3107\u20133117","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-024-01970-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-024-01970-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-024-01970-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:52:51Z","timestamp":1738943571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-024-01970-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s11307-024-01970-6","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study and included experimental procedures were approved by Medical Research Ethics Committee of Xiangya Hospital, Central South University (approval no.202401025). The procedures used in this study adhere to the tenets of the Declaration of Helsinki, and all patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Patients signed informed consent regarding publishing their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interests"}}]}}